Xiaofeng Shi

Xiaofeng Shi is development group leader at New England Biolabs.

Articles by Xiaofeng Shi

Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs

ByPauline M. Rudd,Xiaofeng Shi,Christopher H. Taron,Ian Walsh

October 1st 2018

Analytical exoglycosidases are transitioning from being largely academic tools to being suitable for glycan analytics in biopharmaceutical manufacturing.

Latest Updated Articles

Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs
October 1st 2018